Research on the rhythmic interaction between the host’s circadian clock and gut microbiota is driving the paradigm shift in atherosclerosis prevention and treatment from molecular targeted therapy to spatio-temporal dynamic regulation. This evidence concerns the gene CLOCK and atherosclerosis.